Article
The Vbeta13 T Cell Receptor Monoclonal Antibody Reduces Hyaluronan and CD68+, CD3+, and CD8+ Cell Infiltrations to Delay Diabetes in Congenic BB DRLyp/Lyp Rats.
Frontiers in endocrinology - 1 Jan 2021
Bogdani Marika, Faxius Linda, Fex Malin, Ramelius Anita, Wernersson Anya, Mordes John P, Blankenhorn Elizabeth P, Lernmark Åke
Abstract excerpt
The depleting Vβ13a T cell receptor monoclonal antibody (mAb) 17D5 prevents both induced and spontaneous autoimmune diabetes in BB rats. Here it was tested in congenic DRLyp/Lyp rats, all of which spontaneously developed diabetes. Starting at 40 days of age, rats were injected once weekly with either saline, His42 Vβ16 mAb, or 17D5 mAb and monitored for hyperglycemia. Diabetes occurred in 100% (n = 5/5) of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
